Physician profile
James Wade Wilson
NPI 1841400520
$55,221.34
in general payments reported to CMS, 2019-2025
53 companies · $2,519 in 2025
The $2,519 reported for 2025 was more than what 89% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,079 · 2020: $11K · 2021: $11K · 2022: $17K · 2023: $5,854 · 2024: $2,254 · 2025: $2,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,109 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,722 · Travel and Lodging: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,109.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,722.13 |
| Travel and Lodging | $795.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $27,297.61 | 2019-2024 | Yupelri, Yupelri |
| Astrazeneca Pharmaceuticals Lp | $16,488.71 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $2,615.12 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Insmed, INC. | $850.16 | 2019-2025 | Arikayce, Brinsupri |
| Merck Sharp & Dohme LLC | $735.79 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| Mallinckrodt Hospital Products INC. | $627.79 | 2020-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $607.83 | 2019-2025 | Ofev, Jascayd |
| Grifols USA, LLC | $581.04 | 2020-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $546.34 | 2020-2025 | Glassia |
| Genzyme Corporation | $471.93 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $461.23 | 2019-2025 | Dupixent |
| Baxter Healthcare | $416.85 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Janssen Pharmaceuticals, INC | $406.18 | 2020-2024 | Xarelto |
| Electromed, INC. | $392.09 | 2019-2025 | Smartvest |
| Advanced Respiratory, INC | $297.34 | 2019-2021 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $271.71 | 2025 | Rapiblyk |
| Ani Pharmaceuticals, INC. | $233.59 | 2022-2025 | Purified Cortrophin Gel |
| Pulmonx Corporation | $208.44 | 2025 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Gilead Sciences, INC. | $195.56 | 2023 | |
| Viatris Specialty LLC | $160.62 | 2025 | Yupelri |
| United Therapeutics Corporation | $135.19 | 2021-2024 | Tyvaso |
| Paratek Pharmaceuticals, INC. | $132.75 | 2021 | |
| Amgen INC. | $85.30 | 2023-2025 | Tezspire |
| Philips North America LLC | $82.09 | 2019-2024 | (7999) Src Undivided, (Ak6) Vest Therapy |
| Abbvie INC. | $77.13 | 2023-2025 | Avycaz, Teflaro |
| Novartis Pharmaceuticals Corporation | $75.99 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $68.49 | 2019-2020 | |
| Ambu INC. | $44.94 | 2023 | |
| Mayne Pharma Commercial LLC | $43.30 | 2019 | |
| Shire North American Group INC | $41.92 | 2019 | |
| Ceribell, INC. | $37.75 | 2020-2025 | Pocket Eeg Device |
| Edwards Lifesciences Corporation | $36.91 | 2022 | |
| Inari Medical, INC. | $35.83 | 2022 | |
| Mallinckrodt Enterprises LLC | $33.63 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $32.93 | 2021 | |
| Boston Scientific Corporation | $30.85 | 2022 | |
| Vifor Pharma, INC. | $29.82 | 2024 | Zemaira |
| Lilly USA, LLC | $29.71 | 2025 | Zepbound |
| Pfizer INC. | $27.33 | 2023 | |
| Tactile Systems Technology INC | $26.66 | 2022 | |
| Fisher & Paykel Healthcare INC | $26.05 | 2022 | |
| Nabriva Therapeutics, Plc | $25.31 | 2022 | |
| Aimmune Therapeutics, INC. | $24.44 | 2025 | Zenpep |
| Vapotherm INC | $24.40 | 2019 | |
| Inogen, INC. | $21.42 | 2022 | |
| Inspire Medical Systems, INC. | $19.38 | 2023 | Inspire |
| Ethicon INC. | $17.47 | 2025 | Monarch Platform |
| Chiesi USA, INC. | $16.36 | 2019 | |
| Medtronic, INC. | $16.04 | 2025 | O-Arm |
| Breas Medical, INC. | $16.04 | 2025 | Vivo 45 Ls |
| Olympus America INC. | $15.04 | 2021 | |
| Circassia INC. | $13.10 | 2019 | |
| Allergan, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.